Frequently Asked Questions
The market is segmented based on , By Formulations (Type, Device Type, Accessories), Canister Type (Plain Canister, Coated Canister), Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Cystic Fibrosis, Allergic Rhinitis, Other), End-User (Hospitals and Clinics, Home Care Settings) – Industry Trends and Forecast to 2030.
.
The Global Pulmonary Drug Delivery Market size was valued at USD 47.85 USD Billion in 2022.
The Global Pulmonary Drug Delivery Market is projected to grow at a CAGR of 5.4% during the forecast period of 2023 to 2030.
The major players operating in the market include , F. Hoffmann,La Roche Ltd , MannKind Corporation , OMRON Healthcare , Mylan N.V , 3M , Koninklijke Philips N.V. , Merck & Co. , Teva Pharmaceutical Industries , Sunovion Pharmaceuticals , PARI GmbH , Jabil , AstraZeneca , Boehringer Ingelheim International GmbH. , GSK plc. , Novartis AG , Aerogen Pharma , Briggs Healthcare , HAAG,STREIT GROUP , Janssen Global Services LLC , AptarGroup ,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
